Key Market Players:
if someone doesn’t have time to read your article. Here is what is worth noting
- Mesoblast Ltd.
- Celgene Corporation
- Athersys, Inc.
- Osiris Therapeutics, Inc.
- Pluristem Therapeutics, Inc.
- Vericel Corporation
- NuVasive, Inc.
- BrainStorm Cell Therapeutics, Inc.
- Takeda Pharmaceutical Company Limited
- Cynata Therapeutics Limited
- ReNeuron Group plc
- Regeneus Ltd.
- StemCells Inc.
- Cytori Therapeutics, Inc.
- Pharmicell Co., Ltd.
MESO Nasdaq update, page-5084
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
0.070(6.45%) |
Mkt cap ! $1.318B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.20 | $1.11 | $20.88M | 17.94M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 59978 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 34019 | 3 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.15 |
Change
0.070 ( 5.63 %) |
||||
| Open | High | Low | Volume | ||
| $1.12 | $1.20 | $1.12 | 3733217 | ||
| Last updated 15.59pm 06/05/2024 ? | |||||
| MSB (ASX) Chart |